| 1999 |
TRPC3 (and TRPC6) are directly activated by diacylglycerol in a membrane-delimited, protein kinase C-independent manner, establishing them as second-messenger-operated cation channels downstream of phospholipase C. |
Electrophysiology (patch clamp) in heterologous expression system; pharmacological dissection |
Nature |
High |
9930701
|
| 2003 |
Receptor-mediated activation of TRPC3 in intact cells proceeds via diacylglycerol produced by phospholipase C, independently of G proteins, protein kinase C, or IP3; receptor agonists and exogenous DAG are non-additive and DAG metabolism inhibition slows reversal, confirming DAG as the proximal activator. |
Ca2+ imaging, electrophysiology, pharmacological inhibitors, and InsP3R-knockout DT40 cell system |
The Journal of biological chemistry |
High |
12606542
|
| 2001 |
TRPC3 channels are activated independently of IP3 receptors through DAG production from either PLC-γ or PLC-β, demonstrated in DT40 cells with all three InsP3R genes deleted. |
Expression of TRPC3 in DT40 InsP3R triple-knockout cells; Ca2+ imaging; pharmacological inhibition of PLC |
The Journal of biological chemistry |
High |
11466302
|
| 1999 |
TRPC3 is highly enriched in CNS neurons and co-localizes temporally and spatially with TrkB; activation of TrkB by BDNF leads to a PLC-dependent, nonselective cation conductance in pontine neurons that requires TRPC3. |
Immunohistochemistry, electrophysiology in brain slices, antisense knockdown |
Neuron |
High |
10677043
|
| 2003 |
N-linked glycosylation at a single extracellular site (e2 loop) is a major determinant of TRPC3 constitutive activity; TRPC3 is monoglycosylated compared to dually glycosylated TRPC6, and engineering an additional glycosylation site into TRPC3 markedly reduces its basal activity. |
Site-directed mutagenesis of NxS/T glycosylation sites, immunoblotting, electrophysiology, Ca2+ imaging in HEK293 cells |
The Journal of biological chemistry |
High |
12970363
|
| 2004 |
Protein kinase G (PKG) directly phosphorylates TRPC3 at Thr-11 and Ser-263, inhibiting store-operated Ca2+ influx mediated by TRPC3; point mutations T11A and S263Q abolish cGMP/PKG-dependent inhibition. |
In vitro PKG phosphorylation assay on purified TRPC3 protein; site-directed mutagenesis; Ca2+ imaging in HEK293 cells stably expressing PKG |
Proceedings of the National Academy of Sciences of the United States of America |
High |
14983059
|
| 2004 |
Protein kinase C negatively regulates TRPC3 by phosphorylating Ser-712; a S712A mutant is resistant to PMA-induced inhibition and shows greater receptor-stimulated Ca2+ entry than wild-type TRPC3. |
Site-directed mutagenesis, in vivo phosphorylation assay, electrophysiology, Ca2+ imaging in HEK293 cells |
Molecular pharmacology |
High |
15533987
|
| 2005 |
PLC-γ1 binds to TRPC3 via complementary partial pleckstrin homology (PH) domains; the partial PH domain of PLC-γ1 interacts with a PH-like domain in TRPC3 to mediate lipid binding and control cell-surface expression of TRPC3. |
Co-immunoprecipitation, domain mapping, gestalt PH-domain algorithm, cell-surface expression assay |
Nature |
High |
15744307
|
| 2006 |
TRPC3 and TRPC4 associate to form a redox-sensitive heteromeric cation channel in endothelial cells; FRET shows close proximity between TRPC4 N-terminus and TRPC3 C-terminus; co-expression generates channels with distinct biophysical properties; dominant-negative TRPC4 suppresses TRPC3-related currents in both HEK293 and native endothelial cells. |
Co-immunoprecipitation, FRET, electrophysiology, dominant-negative suppression in HEK293 and porcine aortic endothelial cells |
The Journal of biological chemistry |
High |
16537542
|
| 2006 |
TRPC3 interacts functionally with RyR1 to regulate gain of SR Ca2+ release during excitation-contraction coupling in skeletal muscle; knockdown of TRPC3 reduces RyR1 Ca2+ release channel activity and alters expression of triadic proteins (TRPC1, calsequestrin, triadin, junctophilin 1). |
Retroviral siRNA knockdown in primary skeletal myoblasts; Mn2+ influx, Ca2+ imaging with Fura-2 and Fluo-4; immunoblot |
The Journal of biological chemistry |
Medium |
16484216
|
| 2008 |
TRPC3 interacts directly with six triadic proteins (TRPC1, JP2, homer, mitsugumin 29, calreticulin, calmodulin) in skeletal muscle in a Ca2+-independent manner, but shows no direct interaction with RyR1; TRPC1 is identified as a physical link between TRPC3 and RyR1. |
MALDI-TOF MS of cross-linked triadic vesicles, co-immunoprecipitation from primary mouse myotubes |
The Biochemical journal |
Medium |
18215135
|
| 2008 |
TRPC3 interacts with RACK1 via N-terminal residues Glu-232, Asp-233, Glu-240, and Glu-244; this interaction determines plasma membrane localization of TRPC3 and controls IP3R-RACK1 association and IP3-dependent intracellular Ca2+ release. |
Site-directed mutagenesis of TRPC3, co-immunoprecipitation, surface expression assay, Ca2+ imaging in HEK293 cells, siRNA knockdown |
The Journal of biological chemistry |
High |
18755685
|
| 2008 |
Erythropoietin regulates Ca2+ influx through TRPC3 via a PLC-γ-mediated process requiring interaction of PLC-γ and IP3R with TRPC3; TRPC3 Tyr-226 is critical for Epo-dependent activation; C-terminal domains (residues 671–746) confer Epo-responsiveness distinguishing TRPC3 from TRPC6. |
Co-immunoprecipitation, site-directed mutagenesis of TRPC3 (Y226F, IP3R-binding domain mutants), Ca2+ imaging in HEK293T cells and primary erythroid precursors, siRNA knockdown of PLC-γ |
The Journal of biological chemistry |
High |
18276585
|
| 2009 |
A gain-of-function point mutation T635A in the S4-S5 linker of TRPC3 causes altered channel gating, impairs Purkinje cell dendritic arbor development, and leads to Purkinje cell loss and cerebellar ataxia in moonwalker mice. |
ENU mutagenesis screen, Sanger sequencing, electrophysiology, histology, behavioral testing in mice |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19351902
|
| 2009 |
The pyrazole compound Pyr3 selectively and directly inhibits TRPC3 channels; the trichloroacrylic amide group confers TRPC3 selectivity; direct action on TRPC3 protein confirmed by photoaffinity labeling. |
Electrophysiology, structure-activity relationship studies, photoaffinity labeling, Ca2+ imaging in DT40 B cells and cardiomyocytes |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19289841
|
| 2010 |
TRPC3 functions both as a Ca2+-permeable channel and a protein scaffold for PKCβ at the plasma membrane; TRPC3 deficiency impairs DAG-activated cation currents and sustained PKCβ translocation to the plasma membrane, reducing ERK activation after BCR stimulation; TRPC3 directly associates with PKCβ. |
TRPC3-deficient DT40 B cells, electrophysiology, live-cell imaging of PKCβ-GFP, co-immunoprecipitation, ERK activation assay |
Journal of cell science |
High |
20179100
|
| 2016 |
TRPC3 physically interacts with NADPH oxidase 2 (Nox2) at specific C-terminal sites, protecting Nox2 from proteasomal degradation and amplifying Ca2+-dependent Nox2 activation; Nox2 also stabilizes TRPC3 protein; disruption of the TRPC3-Nox2 complex by a C-terminal polypeptide abolishes TRPC3-regulated ROS production without affecting TRPC3-mediated Ca2+ influx. |
Co-immunoprecipitation, proteasome inhibitor experiments, C-terminal minipeptide competition, ROS assays, Ca2+ imaging, pressure overload mouse model |
Scientific reports |
High |
27833156
|
| 2016 |
TRPC3 mediates RhoA activation and fibrotic responses through interaction with microtubule-associated GEF-H1; inhibition of TRPC3 attenuates GEF-H1 activation and Rho-mediated fibrosis in pressure-overloaded hearts; Nox2 inhibition also attenuates stretch-induced GEF-H1 activation, placing it downstream of TRPC3-Nox2. |
Proteomic analysis, co-immunoprecipitation, pharmacological TRPC3 inhibition, pressure overload mouse model, RhoA activity assays |
Scientific reports |
High |
27991560
|
| 2017 |
TRPC3 mediates acute catecholamine secretion triggered by the β-arrestin-1-biased AT1R agonist TRV120027; TRV120027 promotes recruitment of TRPC3 or PLCγ to the AT1R-β-arrestin-1 signaling complex; blocking β-arrestin-1–PLCγ interaction with a TAT-P1 peptide abolishes TRPC3 activation. |
Co-immunoprecipitation, TAT-P1 peptide competition, Ca2+ imaging, catecholamine secretion assay, β-arrestin chimera replacement |
Nature communications |
High |
28181498
|
| 2018 |
Cryo-EM structure of human TRPC3 at 4.4 Å resolution reveals a tetrameric two-layer architecture with N-terminal ankyrin repeats and C-terminal coiled-coil contributing to inter-subunit contacts; the related TRPC6 structure with inhibitor BTDM shows the inhibitor wedges between S5-S6 pore domain and voltage sensor-like domain. |
Single-particle cryo-electron microscopy |
Cell research |
High |
29700422
|
| 2022 |
PI(4,5)P2 regulates TRPC3 through three independent modes: (1) PLC-dependent hydrolysis generates DAG that interacts with lipid-binding site 2 in the pore; (2) PI(4,5)P2 interacts with lipid site 1 to inhibit TRPC3 opening and gate DAG access to site 2; (3) PI(4,5)P2 is required for receptor-stimulated changes in pore ionic selectivity. TRPC3 requires recruitment to ER/PM junctions via an FFAT motif that interacts with ER-resident VAPB. |
Electrophysiology, mutagenesis of lipid-binding sites, identification and mutation of FFAT motif, co-immunoprecipitation of VAPB-TRPC3 |
The Journal of cell biology |
High |
35416932
|
| 2006 |
PKC-mediated inhibition of TRPC3 is partly indirect, operating through PKG in vascular endothelial cells; PKG inhibitors significantly reduce PMA-induced inhibition of TRPC3 in native endothelial cells, linking the two kinase pathways. |
Ca2+ imaging, pharmacological inhibitors of PKC and PKG, point mutants T11A-S263Q, endothelial cell experiments |
Journal of cellular physiology |
Medium |
16331690
|
| 2004 |
TRPC3 mediates UTP-induced (pyrimidine receptor-activated) depolarization and constriction of cerebral artery smooth muscle cells, but not myogenic (pressure-induced) responses; TRPC6 mediates myogenic depolarization, indicating differential regulation of closely related channels by receptor vs. mechanical stimuli. |
Antisense oligodeoxynucleotide knockdown of TRPC3 or TRPC6 in cerebral arteries; patch clamp; pressure myography |
American journal of physiology. Heart and circulatory physiology |
Medium |
15604128
|
| 2009 |
TRPC3 and TRPC1 are co-expressed in vascular smooth muscle cells and co-immunoprecipitate; both contribute to UTP-stimulated nonselective cation currents; NO/cGMP/PKG signaling inhibits TRPC1/TRPC3 and this inhibition contributes to NO-mediated vasorelaxation. |
Co-immunoprecipitation, intracellular antibody blockade in patch clamp, PKG inhibitor (KT5823), vessel myograph relaxation assay in rat carotid artery |
American journal of physiology. Heart and circulatory physiology |
Medium |
19502552
|
| 2012 |
TRPC3 and TRPC6 are required for normal mechanosensation: loss of TRPC3 alone shifts rapidly-adapting mechanosensitive currents to intermediate-adapting currents in DRG neurons; double TRPC3/TRPC6 KO silences half of RA-current neurons, impairs light touch, and causes hearing and vestibular deficits; co-expression of TRPC3 and TRPC6 in sensory neuron cell lines induces FM1-43-sensitive mechanically gated currents. |
Single and double KO mice, patch clamp of DRG neurons and cochlear hair cells, behavioral testing, heterologous co-expression |
Open biology |
High |
22724068
|
| 2015 |
TRPC3 co-localizes with NCX1 in cardiomyocytes and forms a micro/nanodomain; TRPC3 activation by GSK1702934A or angiotensin II promotes NCX1 currents and transiently causes spatial uncoupling of TRPC3 from NCX1, leading to Ca2+ overload and arrhythmogenesis; pro-arrhythmic effects are prevented by NCX inhibition. |
Immunocytochemistry colocalization, electrophysiology in TRPC3-overexpressing cardiomyocytes, Langendorff heart preparation, NCX inhibitor 3',4'-dichlorobenzamil |
Cardiovascular research |
Medium |
25631581
|
| 2022 |
TRPC3 acts as a negative regulator of IP3 receptor-mediated Ca2+ release at the ER/mitochondria interface; TRPC3 downregulation in senescent fibroblasts leads to elevated cytosolic/mitochondrial Ca2+ oscillations, increased mitochondrial Ca2+ load, and elevated OXPHOS; re-expression of TRPC3 in senescent cells reduces mitochondrial Ca2+ and promotes escape from oncogene-induced senescence. |
TRPC3 re-expression in senescent cells, mitochondrial Ca2+ imaging, OCR measurement, xenograft tumor assay |
Nature communications |
Medium |
35177596
|
| 2017 |
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy; cardiomyocyte-specific expression of TRPC3 C-terminal minipeptide inhibits TRPC3-Nox2 coupling and suppresses doxorubicin-induced cardiomyocyte size reduction and LV dysfunction without reducing hypoxic stress. |
Cardiomyocyte-specific transgenic minipeptide expression, Nox2 co-IP, morphometric analysis, echocardiography in mice |
JCI insight |
High |
28768915
|
| 2011 |
TRPC3 TRP domain residues (DDKPS) and the distal C-terminal AMP-activated protein kinase (AMPK) binding site are required for erythropoietin-induced TRPC3 activation and cytoskeletal association/plasma membrane insertion; chimeric TRPC6 channels gain Epo responsiveness when given TRPC3 TRP domain plus C2/AMPK site. |
Site-directed mutagenesis, TRPC3/TRPC6 chimeric channels, Ca2+ imaging, cell surface expression assay in HEK293T and primary erythroblasts |
The Journal of biological chemistry |
Medium |
21757714
|
| 2010 |
Thrombin upregulates TRPC3 protein in cortical astrocytes via PAR-1/ERK/JNK/NF-κB signaling; TRPC3-mediated Ca2+ signaling feeds forward to further increase its own expression; TRPC3 knockdown inhibits thrombin-induced astrocyte morphological changes, S100B upregulation, and proliferation. |
siRNA knockdown, pharmacological inhibitors (Pyr3, BAPTA-AM, 2-APB), Western blot, immunofluorescence, proliferation assay in cortical astrocytes and in vivo PAR-1 agonist injection |
The Journal of neuroscience |
Medium |
20881130
|
| 2019 |
TRPC3 regulates triple-negative breast cancer cell proliferation and apoptosis resistance through a TRPC3-RASA4-MAPK signaling cascade: Ca2+ influx through TRPC3 sustains RASA4 localization on the plasma membrane, where it suppresses Ras-MAPK pathway activation. |
Subcellular fractionation, Western blot, Pyr3 pharmacology, dominant-negative TRPC3, proliferation and apoptosis assays, RASA4 membrane localization assay |
Cancers |
Medium |
31003514
|
| 2019 |
TRPC3-Nox2 complex mediates nutritional deficiency-induced cardiomyocyte atrophy through extracellular ATP/P2Y2 receptor signaling; knockdown of either TRPC3 or Nox2 suppresses ATP-mediated Nox2 protein increases, ROS production, and cardiomyocyte atrophy. |
siRNA knockdown of TRPC3 and Nox2, co-IP, ROS measurement, cardiomyocyte size measurement in neonatal rat cardiomyocytes |
Scientific reports |
Medium |
31278358
|
| 2021 |
TRPC3 and NALCN together form sustained inward currents responsible for the slow depolarization driving pacemaking in nigral dopamine neurons; specific blockade of TRPC3 abolishes pacemaking, but TRPC3 KO mice retain normal pacemaking due to compensatory NALCN upregulation. |
Pharmacological TRPC3 blockade, TRPC3 KO and NALCN blockade in mouse substantia nigra slice electrophysiology; NALCN mRNA and protein quantification |
eLife |
High |
34409942
|
| 2012 |
STIM1L, a splice variant of STIM1, binds more abundantly to TRPC3 (and TRPC6) than canonical STIM1, and tends to suppress receptor-operated Ca2+ entry via TRPC3 and TRPC6 more strongly than STIM1; co-immunoprecipitation confirms STIM1L-TRPC3 physical association. |
Co-immunoprecipitation, Ca2+ imaging (thapsigargin and endothelin-1 protocols), HEK293 cells stably expressing ETA receptor |
Biochemical and biophysical research communications |
Medium |
23068106
|
| 2021 |
Progesterone receptor isoform B (PGR-B) suppresses uterine contractility by downregulating TRPC3 (and OXTR) while upregulating PLCL2, reducing oxytocin signaling; PGR-B overexpression in smooth muscle results in prolonged gestation and labor dystocia. |
Transgenic mice overexpressing PGR-A or PGR-B in smooth muscle, uterine RNA sequencing, ex vivo and in vivo contractility measurement, CRISPRa-based functional assay of PLCL1/2 |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
33707208
|
| 2016 |
TRPC3 channels are required for hypothalamic glucose detection: whole-body and MBH-specific TRPC3-deficient mice show impaired anorectic response to intracerebroventricular glucose, blunted insulin secretion response to intracarotid glucose, and reduced Ca2+ responses to glucose in mediobasal hypothalamus GE neurons. |
Constitutive and conditional TRPC3 KO mice, in vivo food intake and insulin secretion assays, in vitro Ca2+ imaging of freshly dissociated MBH neurons, pharmacological inhibition with Pyr3 |
Diabetes |
High |
27899482
|
| 2019 |
TRPC3 is located at T-tubules of embryonic stem cell-derived cardiomyocytes; TRPC3 current contributes to diastolic depolarization (phase 4), local Ca2+ release, and NCX current; reducing TRPC3 current decreases action potential rate and RyR2/phospholamban phosphorylation. |
Immunocytochemistry, whole-cell patch clamp, confocal Ca2+ imaging, combined current and voltage clamp, dominant negative TRPC3 construct in mESC-derived cardiomyocytes |
International journal of cardiology |
Medium |
26512833
|
| 2022 |
PLAA inhibits METTL3 expression via ubiquitin-mediated degradation; METTL3 stabilizes TRPC3 mRNA via m6A modification; reduced TRPC3 expression following PLAA upregulation decreases intracellular Ca2+ and suppresses ovarian cancer cell migration and invasion. |
Co-IP/ubiquitin assay, m6A-seq/RIP, CRISPR KO, Ca2+ imaging, xenograft orthotopic mouse model |
Oncogene |
Medium |
35869392
|